Home / Azithromycin / Czechia
CZ ATC J01FA10 · updated 2 Nov 2026
Azithromycin shortage in Czechia
Is there an Azithromycin shortage in Czechia?
Yes. As of 2 Nov 2026, 1 Azithromycin product is reported short in Czechia, the first since 30 Jul 2026. The company estimate for the return is 30 Nov 2026. Main reason: manufacturing problem.
Also short in United States, Canada, Italy, Spain, Ireland, Switzerland, Sweden, Australia. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | SUMAMED 500MG 500MG INF PLV SOL 5 | Teva Pharmaceuticals CR, s.r.o., Praha | 30 Jul 2026 | 30 Nov 2026 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.